Rega marang bathi mangsa ngarep: CeriBell EEG (CBLL)
CeriBell, Inc. (CBLL) maintains a stable operational backdrop supported by the neutral status of biomedicine, which minimizes the impact of global conflicts. The business relies on the development of diagnostic solutions for the nervous system. Service scalability is ensured through outsourced EEG system production and cloud data storage. This price chart with the 0.00 indicator illustrates the P/E multiple dynamics for the company.
Ringkesan rincian data analitis CeriBell EEG (CBLL)
- kuotasi lan prakiraan analis:
- indikator kapitalisasi bursa perusahaan:
- data ekuitas miturut neraca:
- indikator beban utang lan likuiditas:
Total Utang marang Modal CeriBell, Inc.|CBLL - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas CeriBell, Inc.|CBLL - Utang perusahaan|Rasio utang marang kapitalisasi buku CeriBell Inc|CBLL - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan CeriBell|Rasio cepet ceribell.com
- statistik bathi lan rasio pasar:
CBLL - Asil keuangan resik|Bathi sing dikarepake CeriBell, Inc.|CBLL - Pangali rega marang bathi|Pangali Forward P/E CeriBell Corp|CBLL - Pangali rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan CeriBell Inc|CBLL - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) CeriBell|CBLL - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan ceribell.com|CBLL - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep CeriBell, Inc.
Analisis umum perusahaan:CBLL CeriBell
Investors use this multiple to determine whether an asset is overbought relative to its future earnings. The metric is calculated as the ratio of the stock's market value to its projected annual profit. For CeriBell, Inc. (CBLL), this reflects the pace of organic adoption of diagnostic systems within clinics. Rising earnings expectations typically dampen volatility. When analyzing changes in the company's forward P/E, investors should avoid buying at valuation peaks.
Perusahaan pesaing
Pangali Forward P/E BIIB|NBIX - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Regencell RGC|Pangali mangsa ngarep rega marang bathi AXSM|ACADIA Pharmaceuticals - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi xenon-pharma.com XENE|VKTX: Pangali Forward P/E|SUPN (Supernus Pharmaceuticals, Inc.) - Rega marang bathi mangsa ngarep|CPRX (Catalyst Pharmaceuticals Inc) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Denali Corp DNLI|Rega marang bathi mangsa ngarep Harmony Biosciences (HRMY)|Rega marang bathi mangsa ngarep BHVN (biohavenpharma.com)|Rega marang bathi mangsa ngarep Amylyx Pharmaceuticals, Inc. AMLX|Trevi Therapeutics Inc - Rega marang bathi mangsa ngarep|PRAX: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi AVXL (Anavex Life Sciences Corp)|PRTA: Pangali Forward P/E|ALEC - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Annexon|Rasio rega marang bathi mangsa ngarep OMER (Omeros Corp.)|Pangali Forward P/E NGNE|Prakiraan rega marang bathi AC Immune Inc ACIU|Voyager Therapeutics - Prakiraan rega marang bathi|Kapitalisasi marang proyeksi bathi neumoratx.com (NMRA)|Scilex - Pangali Forward P/E|Tevogen Bio Holdings Inc. (TVGN) - Prakiraan rega marang bathi|ACOG: Pangali Forward P/E|CGTX (Cognition Therapeutics Inc.) - Rega marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Inhibikase Therapeutics|Rega marang bathi mangsa ngarep SAVA|Rega marang bathi mangsa ngarep Assertio Holdings, Inc. (ASRT)|Rega marang bathi mangsa ngarep COYA (coyatherapeutics.com)|Rega marang bathi mangsa ngarep Vistagen VTGN|OVID: Rasio rega marang bathi mangsa ngarep|Acumen Pharmaceuticals - Pangali Forward P/E|Rasio prakiraan rega marang bathi cervomed.com|ATHE (alteritytherapeutics.com) - Prakiraan rega marang bathi|Clene (CLNN) - Pangali Forward P/E|Rega marang bathi mangsa ngarep PepGen Inc|JUNS: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Relmada Therapeutics (RLMD)|ANVS - Rasio prakiraan rega marang bathi|Pangali Forward P/E GRCE (Grace Therapeutics)|AIFF - Prakiraan rega marang bathi|ANEW Medical, Inc. - Pangali Forward P/E|Rasio prakiraan rega marang bathi NeuroSense Therapeutics|Reviva Pharmaceuticals (RVPH) - Rega marang bathi mangsa ngarep|MetaVia - Pangali mangsa ngarep rega marang bathi|NRXS (NeurAxis) - Pangali Forward P/E|Helius Medical Technologies Inc. (HSDT) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E PASG|Rega marang bathi mangsa ngarep NEUP (bionomics.com.au)|Pangali Forward P/E NERV (Minerva Neurosciences)|athira.com (ATHA) - Rasio prakiraan rega marang bathi|ADXN - Rega marang bathi mangsa ngarep|ALZN: Rega marang bathi mangsa ngarep|cyclerion.com (CYCN) - Rega marang bathi mangsa ngarep|PTIX (Protagenic Therapeutics, Inc.) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi KTTA|CRGT: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E ATXI|Kapitalisasi marang proyeksi bathi Brainstorm Cell Therapeutics Inc.|Rega marang bathi mangsa ngarep Cara Therapeutics, Inc CARA|CHRO: Rasio rega marang bathi mangsa ngarep|Eliem - Pangali Forward P/E|Intra-Cellular Therapies (ITCI) - Prakiraan rega marang bathi|LBPH (Longboard Pharmaceuticals, Inc.) - Prakiraan rega marang bathi|MRNS - Kapitalisasi marang proyeksi bathi|NKGN (NKGen) - Pangali Forward P/E|Prakiraan rega marang bathi NeuroBo Pharma (NRBO)|Pangali Forward P/E SAGE|Rega marang bathi mangsa ngarep SNPX (synaptogen.com)|Rega marang bathi mangsa ngarep Trevena TRVN|Vigil Neuroscience Inc. - Rega marang bathi mangsa ngarep|WENA - Rega marang bathi mangsa ngarep|CERE: Rega marang bathi mangsa ngarep
